Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Century Therapeutics Inc (NASDAQ: IPSC) closed at $0.61 in the last session, down -4.52% from day before closing price of $0.63. In other words, the price has decreased by -$4.52 from its previous closing price. On the day, 0.8 million shares were traded.
Ratios:
We take a closer look at IPSC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.70 and its Current Ratio is at 11.70. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 08, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On August 28, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $28 to $5.
On December 27, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $19.Chardan Capital Markets initiated its Buy rating on December 27, 2022, with a $19 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 09 ’25 when Carr Douglas sold 4,904 shares for $0.62 per share. The transaction valued at 3,050 led to the insider holds 405,982 shares of the business.
Farid Adrienne sold 552 shares of IPSC for $343 on Jun 09 ’25. The Chief Operations Officer now owns 250,141 shares after completing the transaction at $0.62 per share. On Jun 09 ’25, another insider, Pfeiffenberger Brent, who serves as the President and CEO of the company, sold 475 shares for $0.62 each. As a result, the insider received 295 and left with 1,681,783 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.45 while its Price-to-Book (P/B) ratio in mrq is 0.22.
Stock Price History:
Over the past 52 weeks, IPSC has reached a high of $3.46, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is 14.96%, while the 200-Day Moving Average is calculated to be -39.70%.
Shares Statistics:
A total of 86.15M shares are outstanding, with a floating share count of 40.59M. Insiders hold about 52.89% of the company’s shares, while institutions hold 28.86% stake in the company.
